Coronary Revascularization Versus Optimal Medical Therapy in Renal Transplant Candidates With Coronary Artery Disease: A Systematic Review and Meta‐Analysis
Background Coronary artery disease (CAD) is highly prevalent in patients with chronic kidney disease and is a common cause of mortality in end‐stage renal disease. Thus, patients with end‐stage renal disease are routinely screened for CAD before renal transplantation. The usefulness of revasculariza...
Main Authors: | Muhammad U. Siddiqui, Joey Junarta, Gregary D. Marhefka |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-02-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.023548 |
Similar Items
-
Myocardial revascularization in renal transplant patients
by: Daniel de Souza Delgado, et al.
Published: (2002-11-01) -
Mortality rate after coronary revascularization in heart failure patients with coronary artery disease
by: Vanessa Nader, et al.
Published: (2023-08-01) -
The association of uric acid levels with presence of coronary artery disease (CAD) and need for revascularization in renal transplant candidates
by: Eslami M, et al.
Published: (2009-04-01) -
Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization
by: Ziad A. Ali, et al.
Published: (2021-05-01) -
Revascularization in Patients With Spontaneous Coronary Artery Dissection: Where Are We Now?
by: Chayakrit Krittanawong, et al.
Published: (2021-07-01)